Allspring Global Investments’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$145K Sell
17,394
-1,011
-5% -$8.45K ﹤0.01% 1569
2025
Q1
$144K Buy
18,405
+6,453
+54% +$50.7K ﹤0.01% 1679
2024
Q4
$178K Buy
11,952
+28
+0.2% +$417 ﹤0.01% 1685
2024
Q3
$182K Sell
11,924
-884
-7% -$13.5K ﹤0.01% 1688
2024
Q2
$195K Sell
12,808
-132
-1% -$2.01K ﹤0.01% 1711
2024
Q1
$244K Buy
12,940
+1,090
+9% +$20.6K ﹤0.01% 1665
2023
Q4
$226K Buy
11,850
+2,516
+27% +$48.1K ﹤0.01% 1663
2023
Q3
$168K Buy
9,334
+230
+3% +$4.13K ﹤0.01% 1808
2023
Q2
$185K Sell
9,104
-6,968
-43% -$142K ﹤0.01% 1833
2023
Q1
$293K Buy
16,072
+3,703
+30% +$67.5K ﹤0.01% 1720
2022
Q4
$256K Sell
12,369
-828
-6% -$17.1K ﹤0.01% 1763
2022
Q3
$345K Buy
13,197
+3,315
+34% +$86.7K ﹤0.01% 1665
2022
Q2
$250K Sell
9,882
-9,668
-49% -$245K ﹤0.01% 1753
2022
Q1
$616K Sell
19,550
-700
-3% -$22.1K ﹤0.01% 2133
2021
Q4
$819K Buy
+20,250
New +$819K ﹤0.01% 2055